Mexico demands Boehringer Ingelheim/Sanofi animal health divestitures
European drugmakers Boehringer Ingelheim and Sanofi will have to sell five animal health vaccines to an approved third-party purchaser in Mexico to clear one of the few remaining antitrust hurdles facing the €22.8 billion asset swap.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.